These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28345492)

  • 1. Rasburicase-induced methemoglobinemia: The eyes do not see what the mind does not know.
    Ibrahim U; Saqib A; Mohammad F; Atallah JP; Odaimi M
    J Oncol Pharm Pract; 2018 Jun; 24(4):309-313. PubMed ID: 28345492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rasburicase-Induced Methemoglobinemia in a Patient with Glucose-6- Phosphate Dehydrogenase Deficiency.
    Khan M; Paul S; Farooq S; Oo TH; Ramshesh P; Jain N
    Curr Drug Saf; 2017; 12(1):13-18. PubMed ID: 28078984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality following rasburicase-induced methemoglobinemia.
    Bucklin MH; Groth CM
    Ann Pharmacother; 2013 Oct; 47(10):1353-8. PubMed ID: 24259700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rasburicase-Induced Methemoglobinemia in a Patient with Aggressive Non-Hodgkin's Lymphoma.
    Alessa MA; Craig AK; Cunningham JM
    Am J Case Rep; 2015 Sep; 16():590-3. PubMed ID: 26334783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rasburicase causing severe oxidative hemolysis and methemoglobinemia in a patient with previously unrecognized glucose-6-phosphate dehydrogenase deficiency.
    Cheah CY; Lew TE; Seymour JF; Burbury K
    Acta Haematol; 2013; 130(4):254-9. PubMed ID: 23860572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. I.V. ascorbic acid for treatment of apparent rasburicase-induced methemoglobinemia in a patient with acute kidney injury and assumed glucose-6-phosphate dehydrogenase deficiency.
    Reeves DJ; Saum LM; Birhiray R
    Am J Health Syst Pharm; 2016 May; 73(9):e238-42. PubMed ID: 27099330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rasburicase-induced methemoglobinemia in two African-American female patients: an under-recognized and continued problem.
    Roberts DA; Freed JA
    Eur J Haematol; 2015 Jan; 94(1):83-5. PubMed ID: 24750455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare Case of Transcutaneous Oxygen Desaturation in a Cancer Patient: A Case Report and Diagnostic Approach for a Recurrent Problem.
    Bachmann KF; Nebiker M; Johner C; Bregy R; Schaller A; Novak U; Jakob SM
    A A Pract; 2019 Feb; 12(4):96-98. PubMed ID: 30052534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rasburicase-induced Methemoglobinemia: A Case Report and Literature Review.
    Pirrone I; Farruggia P; Cacciatore F; Giambona A; Guarina A; Marcello AP; Mosa C; Scalzo S; D'Angelo P
    J Pediatr Hematol Oncol; 2021 Aug; 43(6):e886-e890. PubMed ID: 33122582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Report of two cases of rasburicase-induced methemoglobinemia.
    Kizer N; Martinez E; Powell M
    Leuk Lymphoma; 2006 Dec; 47(12):2648-50. PubMed ID: 17169811
    [No Abstract]   [Full Text] [Related]  

  • 11. Methemoglobinemia induced by rasburicase in a pediatric patient: a case report and literature review.
    Ng JS; Edwards EM; Egelund TA
    J Oncol Pharm Pract; 2012 Dec; 18(4):425-31. PubMed ID: 22190578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolysis and methemoglobinemia secondary to rasburicase administration.
    Browning LA; Kruse JA
    Ann Pharmacother; 2005 Nov; 39(11):1932-5. PubMed ID: 16204390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rasburicase-Induced Methemoglobinemia.
    Ahmed M; Sanchez T; Norgbe S; Picking CR; Millner PG
    Cureus; 2021 Apr; 13(4):e14406. PubMed ID: 33987056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalase deficiency may complicate urate oxidase (rasburicase) therapy.
    Góth L; Bigler NW
    Free Radic Res; 2007 Sep; 41(9):953-5. PubMed ID: 17729111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational use of rasburicase for the treatment and management of tumor lysis syndrome.
    Shaikh SA; Marini BL; Hough SM; Perissinotti AJ
    J Oncol Pharm Pract; 2018 Apr; 24(3):176-184. PubMed ID: 28077046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rasburicase therapy may cause hydrogen peroxide shock].
    Góth L
    Orv Hetil; 2008 Aug; 149(34):1587-90. PubMed ID: 18708312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome.
    Vadhan-Raj S; Fayad LE; Fanale MA; Pro B; Rodriguez A; Hagemeister FB; Bueso-Ramos CE; Zhou X; McLaughlin PW; Fowler N; Shah J; Orlowski RZ; Samaniego F; Wang M; Cortes JE; Younes A; Kwak LW; Sarlis NJ; Romaguera JE
    Ann Oncol; 2012 Jun; 23(6):1640-5. PubMed ID: 22015451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methemoglobinemia and hemolytic anemia after rasburicase administration in a child with leukemia.
    Bauters T; Mondelaers V; Robays H; De Wilde H; Benoit Y; De Moerloose B
    Int J Clin Pharm; 2013 Jun; 35(3):303-5. PubMed ID: 21057874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rasburicase in the prevention and treatment of tumour lysis syndrome.
    Mayne N; Keady S; Thacker M
    Intensive Crit Care Nurs; 2008 Feb; 24(1):59-62. PubMed ID: 17698360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rasburicase-induced haemolysis and methemoglobinemia: an ongoing issue.
    Madanat L; Schoenherr D; Wey E; Gupta R
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33727299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.